Image

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Comparing two maintenance therapies after stem cell transplant for multiple myeloma.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Purpose: This study looks at how well two medicines, iberdomide and lenalidomide, work when given to patients with multiple myeloma after a special procedure called autologous stem cell transplantation (ASCT). Multiple myeloma is a type of cancer that affects blood cells. ASCT is a treatment where a patient's own stem cells are used to help fight the cancer.

Who Can Join: People with a new diagnosis of multiple myeloma who have had certain treatments and the ASCT procedure. They should not have other serious health problems or other types of cancer.

Who Cannot Join: People whose myeloma has gotten worse after ASCT or who have certain other health problems.

  • Study involves taking either iberdomide or lenalidomide after ASCT.
  • Participants need to be within 12-15 months after starting earlier treatments.
  • There are certain health criteria to meet before joining.

This study is important to find out which medicine helps patients stay healthy longer after their ASCT treatment.

Print
Study details
    Multiple Myeloma

NCT05827016

Bristol-Myers Squibb

17 May 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.